Healthcare News

  Global Antifreeze Protein Market - Impact of the Coronavirus (COVID-19) Pandemic Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 172 million cases and 3.7 million deaths due to coronavirus (COVID-19) were reported till June 06, 2021, across the globe. Impact of COVID-19 on Demand and Supply of Antifreeze Proteins The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has negatively impacted the entire supply chain of the pharmaceutical industry, food & beverage industry, cosmetics industry, and others mainly due to strict lockdown in several regions. However, the demand for antifreeze proteins is increasing in thi

  Developed regions such as North America, typically the U.S. have shown the most promising signs when it comes to the bioinformatics platforms market. This is due to high adoption of new and advanced technology, which is complemented by continuous research and development activates in the region. Similarly, Asia Pacific is witnessing increased interest in the field of bioinformatics platforms due to the presence of skilled personnel. Bioinformatics Platforms are collections of software applications designed to facilitate the analysis of biological information. The applications and their main functions are divided into three categories, these are Cloning Lines of Action, Gene Regulation, and Gene Function. They all can be combined into one application for better functionality. However, the applications vary depending on the needs of the user and the complexity of the job. Bioinformatics is widely used in research and development activities for either drug discovery, clinical diagnost

  Osteonecrosis is a medical term meaning "bone death." It is caused by an inflammation of the hip joint due to a reduction in blood supply. This type of bone disease can have an extensive impact on the quality of life of individuals suffering from it, making the treatment of osteonecrosis extremely important. Market Dynamics High prevalence of osteonecrosis is expected to propel growth of the osteonecrosis treatment market. For instance, according to the study, ‘Epidemiology of osteonecrosis among older adults in Sweden’, published in Springer in January 2019, the 10-year risk of osteonecrosis was 0.4% and the incidence rate was 4.7 cases/10000 person-years. Moreover, high prevalence of osteoporosis is also expected to aid in growth of the osteonecrosis treatment market. For instance, according to a study published online in February 2020 in the Journal of Clinical Endocrinology & Metabolism, for denosumab-treated women with postmenopausal osteoporosis, invasive oral

  Market Overview: Endoscope reprocessing devices are those which are made to kill the organisms in the reusable endoscopes using high disinfectants or liquid chemical solutions to expose the exterior surfaces and the interior channels. Manual cleaning, sterilization, documentation, leak testing and pre –cleaning are some of the steps performed in endoscopy reprocessing. Competitive Landscape: The major players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V., Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB.  Key Market Drivers: Rising prevalence of colorectal cancer and other endoscopy-related diseases are anticipated to augment the growth of the global endoscope reprocessing device market. For instance, as per the American Cancer Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030 rectal ca

  Market Overview:   Generic oncology sterile injectable are widely used for the treatment of cancers prostate, breast, colorectal, melanoma, lung, and bronchus. They have the same active ingredients as that of the branded version, with only the inactive contents of the drugs being different.   Competitive Landscape: Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc. Key Market Drivers: Growing prevalence of chronic disease such as breast, prostate, colorectal, melanoma, lung, and bronchus is driving growth of the generic oncology sterile injectable market . According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Increasing partnership and collaboration in the field of generic oncology sterile injectable is again fostering market

  Market Overview: Telerehabilitation is the application of information and communication technologies to provide rehabilitation services to patients or other healthcare professionals. It is also referred to as telecare, and it empowers individuals with a disability to take charge of their health and personal care. Using telerehabilitation services, patients can receive the same care as patients in a local health care facility. Competitive Landscape: 270 Vision Ltd., CoRehab srl, SWORD Health, S.A., MIRA Rehab Limited, re.flex, Evolv Rehabilitation Technologies S.L., Brontes Processing Ltd., Bridgeway Senior Healthcare, Rehametrics, MindMaze , DIH Medical, and Doctor Kinetic Key Market Drivers: Increasing number of partnership and collaboration among key players is a major factor augmenting growth of the market. For instance, in October 2021, WizeCare Partners with Essen Health Care to advance value-based care through personalized all-in-one telerehabilitation platform. Adv